References
"FDA Updates Hormone Therapy Information for Post Menopausal Women."
FDA News/Press Release, February 10, 2004. http://www.fda.gov.
Accessed August 2005.
"Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women.
FDA/Center for Drug Evaluation and Research." http://www.fda.gov.
Last updated: August 3, 2005. Accessed August 2005.
Progestins for Noncontraceptive Use (Systemic). MedLine Plus. http://www.nlm.nih.gov
Last updated: April 14, 2005. Accessed August 2005.
Uterine Fibroid Embolization, a Minimally Invasive Treatment for Uterine Fibroids;
Highly Effective, Widely Available Interventional Radiology Treatment is Underutilized.
Society for Interventional Radiology fact sheet.
Study Shows Minimally Invasive Uterine Fibroid Embolization Treatment Offers
Much Quicker Recovery, Shorter Hospital Stays, and is Safer with Lower Adverse
Event Rates than Myomectomy Surgery. Society for Interventional Radiology fact
sheet. March 26, 2004.
Lee, B-S, Margolin, SB, Nowak, RA. "Perdfenidone: A Novel Pharmacological
Agent that Inhibits Leiomyoma Cell Proliferation and Collagen Production."
Journal of Clinical Endocrinology and Metabolism. 1998; 83(1); 219-223.
"Microwave Endometrial Ablation (MEA) System." Center for Devices
and Radiological Health (CDRH) Consumer Information New Device Approval. FDA
News/Press Release, January 21, 2004. http://www.fda.gov.
Accessed August 2005.
FDA Approves Lower Dose of Prempro, A Combination Estrogen and Progestin Drug
for Postmenopausal Women. FDA News/Press Release, March 13, 2003. http://www.fda.gov.
Accessed August 2005.
"FDA Approves New Labels for Estrogen and Estrogen with Progestin Therapies
for Postmenopausal Women Following Review of Women's Health Initiative Data."
FDA News/Press Release. January 8, 2003. http://www.fda.gov.
Accessed August 2005.
" PMS: Symptoms & Solutions." National Women's Health Resource
Center, Washington, DC: April 2002.
Parsey, K. Pong, A. "An Open-Label, Multicenter Study to Evaluate Yasmin,
a Low-Dose Combination Oral Contraceptive Containing Drospirenone, a New Progesterone."
Contraception. Elsevier Science, Inc. 2000; 61; 105-111.
"Medical Treatment for Fibroids" Center for Uterine Fibroids, Brigham
and Women's Hospital Departments of Obstetrics/Gynecology and Pathology. Updated
May 2003. http://www.fibroids.net.
Accessed August 2005.
The American College of Obstetricians and Gynecologists, ACOG Practice Bulletin,
Clinical Management Guidelines for Obstetricians-Gynecologists, Number 15, April
2000.
"Diagnosis and Treatment of Premenstrual Syndrome (PMS)" Medical
College of Wisconsin (MCW) HealthLink. Updated Aug. 10, 2000.
http://healthlink.mcw.edu.
Accessed August 2005.
"PMS Treatment: Serotonergic Drugs" University of Kentucky Dept.
of Obstetrics and Gynecology. Modified March 21, 2000.
http://www.mc.uky.edu.
Accessed August 2005.
"Cryosurgical Device to Treat Menorrhagia" American Family Physician:
Clinical Briefs. Sept. 15, 2001.
http://www.aafp.org.
Accessed August 2005.
"Hydro ThermAblator®." Center for Devices and Radiological Health:
Medical Device Approvals.
Updated June 4, 2001. http://www.fda.gov.
Accessed August 2005.
"HerOption™ Uterine Cryoblation Therapy™ System." Center
for Devices and Radiological Health: Medical Device Approvals. Updated July
11, 2001. http://www.fda.gov.
Accessed August 2005.
"NovaSure™ Impedance Controlled Endometrial Ablation System."
NovaSure/Cytyc Corporation. http://www.novacept.com.
Accessed August 2005.
"Abnormal Uterine Bleeding: Treatment Options." American Society
for Reproductive Endocrinologists. National Women's Health Report. Vol. 20 No.
3. June 1998. pp. 1-5.
Bayer, S. DeCherney, A. "Clinical Manifestations and Treatment of Dysfunctional
Uterine Bleeding." Journal of American Medical Association. Vol. 269 No.
14. pp. 1823-1828.
Archer, D. "Diagnosis and Management of Abnormal Uterine Bleeding."
Menopause Management. May/June 1997. pp. 22-24.
"Abnormal Uterine Bleeding: ACOG Patient Education."American College
of Obstetrics and Gynecology. (Patient Education Pamphlet) June 1996.
"Gynecare Thermachoice Uterine Balloon Therapy System." Gynecare/Ethicon
Incorporated/Johnson & Johnson. http://www.gynecare.com.
Accessed August 2005.
"FDA Approves New Device to Treat Uterine Fibroids." FDA News Release.
October 22, 2004.
http://www.fda.gov.
Accessed August 2005.
Shaw RW. Assessment of medical treatments for menorrhagia. Br J Obstet Gynaecol.
1994 Jul;101 Suppl 11:15-8.
New Important Labeling Information. Ortho Evra website. January 2005. Available
at: http://www.orthoevra.com.
Accessed November 2005.
| |
|
View References for this Health Topic
|
Create Date: 2/2/02
Date Last Updated: 3/16/06
Review Date: 2/4/06
|
|
